Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer
US-10519197-B1 · Dec 31, 2019 · US
US11724995B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11724995-B2 |
| Application number | US-201917287404-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 22, 2019 |
| Priority date | Oct 22, 2018 |
| Publication date | Aug 15, 2023 |
| Grant date | Aug 15, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Decalin derivative compounds of formula (I) are provided, including processes for preparation thereof, and pharmaceutical compositions including the decalin derivative compounds. Methods are provided for treating blood related disorders, such as sickle cell anemia, in a subject in need thereof using a compound of formula (I).
Opening claim text (preview).
The invention claimed is: 1. A process for preparing a decalin derivative compound of formula (A8): where: R 1 , R 2 , R 4 , and R 5 , are independently chosen from: hydrogen; or unsubstituted C 1 -C 10 alkyl or substituted C 1 -C 10 alkyl; or unsubstituted C 2 -C 10 alkenyl or C 2 -C 10 alkenyl substituted with hydroxy, alkoxy, ester, or —OTBS; or amino, halo, hydroxyl, carbonyl, thiocarbonyl, carboxylate, alkoxy, carbamide, carbamate, or hydrazine, the process comprising: (a) protecting and following allylic oxidation of a compound according to formula (A5): where R 6 is hydrogen, to afford a compound according to formula (A6): (b) epoxidating and deprotecting the compound according to formula (A6) to afford a compound according to formula (A7): and (c) reducing the compound according to formula (A7) to afford the compound according to formula (A8), wherein: R 1 , R 2 , R 4 , and R 5 in formulas (A5), (A6), (A7) are as defined in the compound of formula (A8); and Pg in the compounds of formulas (A6) and (A7) is a protecting group. 2. A process for the preparation of a decalin derivative compound of formula (A13): where: R 1 , R 2 , R 4 , R 5 , R 7 , and R 9 are independently chosen from: hydrogen; or unsubstituted C1-C 10 alkyl or substituted C 1 -C 10 alkyl; or unsubstituted C 2 -C 10 alkenyl or C 2 -C 10 alkenyl substituted with hydroxy, alkoxy, ester, or —OTBS; or amino, halo, hydroxyl, carbonyl, thiocarbonyl, carboxylate, alkoxy, carbamide, carbamate, or hydrazine, or wherein R 1 , R 2 , R 4 , R 5 , R 7 , and R 9 may be joined to form an unsubstituted or substituted fused cyclic ring, and represents a single or double bond, the process comprising: (a) halogenating a compound according to formula (A9): to afford a compound according to formula (A10): where X is a halogen; (b) performing Suzuki Coupling on the compound according to formula (A10) in the presence of a compound according to formula (X): to afford a compound according to formula (A11): (c) forming an epoxide on the compound according to formula (A11) to afford a compound according to formula (Al2): and (d) reducing the compound according to formula (Al2) to afford the compound according to formula (A13), wherein: R 1 , R 2 , R 4 , R 5 , R 7 , and R 9 in of formulas (A9), (A10), (X), (A11), (Al2) are as defined in formula (A13). 3. A process for preparing a decalin derivative compound of formula (A21): where: R 1 , R 2 , R 4 , R 5 , R 7 , and R 10 are independently chosen from: hydrogen; or unsubstituted C 1 -C 10 alkyl or substituted C 1 -C 10 alkyl; or unsubstituted C 2 -C 10 alkenyl or C 2 -C 10 alkenyl substituted with hydroxy, alkoxy, ester, or —OTBS; or amino, halo, hydroxyl, carbonyl, thiocarbonyl, carboxylate, alkoxy, carbamide, carbamate, or hydrazine, and wherein any of R 1 , R 2 , R 4 , R 5 , R 7 , or R 10 may be joined to form an unsubstituted or substituted fused cyclic ring, the process comprising: (a) undergoing ozonolysis on a compound according to formula (A14): to afford a compound according to formula (A15): (b) rearranging the compound according to formula (A15) to afford a compound according to formula (A16): (c) reducing and protecting the compound according to formula (A16) to afford a compound according to formula (A17): where R 9 is independently chosen from: hydrogen; or unsubstituted C 1 -C 10 alkyl or substituted C 1 -C 10 alkyl; or unsubstituted C 2 -C 10 alkenyl or C 2 -C 10 alkenyl substituted with hydroxy, alkoxy, ester, or —OTBS, or amino, halo, hydroxyl, carbonyl, thiocarbonyl, carboxylate, alkoxy, carbamide, carbamate, or hydrazine; (d) epoxidating and reducing the compound according to formula (A17) to afford a compound according to formula (A18): (e) oxidating, deprotecting, and rearranging the compound according to formula (A18), to afford a compound according to formula (A19): hydrogenating the compound according to formula (A19) to afford a compound according to formula (A20): and (g) oxidating the compound according to formula (A20) to afford the compound according to formula (A21), wherein: R 1 , R 2 , R 4 , R 5 , R 7 , and R 10 in the compounds of formulas (A14), (A15), (A16), (A17), (A18), (A19), and (A20), are as defined in the compound of formula (A21); and TBS in formulas (A17) and (A18) is tert-butyldimethylsilyl. 4. A process for preparing a decalin derivative compound of formula (A23) or formula (A25): where: R′, R 2 , R 4 , R 5 , R 7 , and R 10 are independently chosen from: hydrogen; or unsubstituted C 1 -C 10 alkyl or substituted C 1 -C 10 alkyl; or unsubstituted C 2 -C 10 alkenyl or C 2 -C 10 alkenyl substituted with hydroxy, alkoxy, ester, or —OTBS; or amino, halo, hydroxyl, carbonyl, thiocarbonyl, carboxylate, alkoxy, carbamide, carbamate, or hydrazine, wherein any of R 1 , R 2 , R 4 , R 5 , R 7 , and R 10 may be joined to form an unsubstituted or substituted fused cyclic ring, the process comprising: dihydroxylating a compound according to formula (A22): wherein R 6 is hydrogen and wherein R 1 , R 2 , R 4 , R 5 , R 7 , and R 10 in formula (A22) are as defined in the compound according to formula (A23) to afford the compound according to formula (A23); or dihydroxylating a compound according to formula (A24): wherein R
by aldehydo- or ketonic radicals · CPC title
containing rings other than six-membered aromatic rings · CPC title
containing hydroxy groups · CPC title
containing ether groups, [IMAGE cpc-sch-C07C-0958.gif] groups,[IMAGE cpc-sch-C07C-0959.gif] groups, or[IMAGE cpc-sch-C07C-0960.gif] groups · CPC title
having two rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.